Detalhe da pesquisa
1.
Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies.
J Gastroenterol Hepatol
; 31(10): 1674-1683, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26936417
2.
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C.
Hum Genet
; 134(3): 279-89, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25515861
3.
Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.
J Gastroenterol Hepatol
; 30(9): 1384-90, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778685
4.
[Combined telaprevir plus ribavirin and pegylated interferon therapy for patients with chronic hepatitis C].
Nihon Rinsho
; 73(2): 259-65, 2015 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-25764680
5.
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy.
Dig Dis
; 30(6): 554-60, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23258094
6.
Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing.
J Gastroenterol
; 51(3): 260-70, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26245700
7.
Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C.
J Gastroenterol
; 49(2): 363-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081655
8.
A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection.
Antivir Ther
; 19(5): 491-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24451122
9.
A multicenter study to clarify the optimal HCV-RNA negative period during combined therapy with pegylated interferon plus ribavirin in patients with chronic hepatitis caused by HCV genotype 2.
Intern Med
; 51(1): 9-15, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22214617